Intuitive Surgical, Inc.

ISRG Healthcare Medical Instruments & Supplies

Intuitive Surgical, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $10.1 billion, up 20.5% from fiscal 2024. In the quarter to June 2026, revenue grew 18.5%, EPS grew 25.5% and free cash flow grew 69.3%, each against the same quarter a year earlier. Member of the S&P 500 and Nasdaq 100; revenue growth for five consecutive years, operating cash flow growth for three.

426.70 1.16 −0.27%
Market cap
$151.2B
P/E
48.3×
Fwd P/E
46.4×
Dividend yield
—
F-score
7/9
Altman Z
50.09
Beneish M
−2.43
Dividend safety
n/a
Jun '26 Mar '26 Dec '25 Sep '25 Older periods
P/E ratio
44.99 55.08 70.71 58.16

+8 more quarters

P/S ratio
12.76 15.46 20.08 16.59
P/FCF ratio
43.08 56.80 81.16 70.22
P/Operating CF
132.72 179.41 226.48 189.63
P/B ratio
7.70 9.30 11.27 9.36
EV/Sales
12.29 15.03 19.49 16.08
EV/EBITDA
31.88 40.20 54.16 45.00
EV/FCF
41.49 55.23 78.77 68.06
Current Ratio
4.96 4.61 4.87 4.73
Net Debt/EBITDA
(4.37) (4.32) (5.61) (5.13)
Debt/Equity
0.00 0.00 0.00 0.00
Earnings Yield
2.22% 1.82% 1.41% 1.72%
Free Cash Flow Yield
2.32% 1.76% 1.23% 1.42%
Free Cash Flow per Share
2.68 2.41 2.05 2.06
Book value per Share
51.67 49.58 50.27 47.79
Free Cash Flow
948.40 854.60 730.00 735.60
EV/EBIT
39.29 49.36 66.61 54.89
Other line items

Show all line items

Columns are period end dates